Qube Research & Technologies (QRT)’s Anavex Life Sciences AVXL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-388,718	Closed	-$1.38M	–	3531
2025 Q4	$1.38M	Buy	+388,718	New	+$2.38M	﹤0.01%	2422
2023 Q4	–	Sell	-11,796	Closed	-$77.3K	–	4330
2023 Q3	$77.3K	Sell	11,796 -176,158	-94%	-$1.4M	﹤0.01%	2743
2023 Q2	$1.53M	Buy	+187,954	New	+$1.61M	0.01%	1150
2023 Q1	–	Sell	-29,259	Closed	-$271K	–	2535
2022 Q4	$271K	Sell	29,259 -2,670	-8%	-$28.5K	﹤0.01%	1689
2022 Q3	$330K	Sell	31,929 -32,165	-50%	-$339K	﹤0.01%	1603
2022 Q2	$642K	Buy	+64,094	New	+$607K	﹤0.01%	1304
2022 Q1	–	Sell	-19,797	Closed	-$343K	–	2434
2021 Q4	$343K	Buy	+19,797	New	+$376K	﹤0.01%	1739

Other funds holding AVXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Qube Research & Technologies (QRT)'s AVXL Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 388,718 shares — an estimated $1.38M sold.

Qube Research & Technologies (QRT) first reported a position in AVXL in Q4 2021 and held it in 7 quarters. The position peaked at $1.53M in Q2 2023. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

Qube Research & Technologies (QRT) reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 388,718 Anavex Life Sciences shares in Q1 2026, an estimated $1.38M.
Qube Research & Technologies (QRT) first reported a position in Anavex Life Sciences in Q4 2021 and held it in 7 quarters.
Qube Research & Technologies (QRT)'s Anavex Life Sciences position peaked at $1.53M in Q2 2023.
190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.